213 related articles for article (PubMed ID: 37197134)
1. A Study of Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Andhra Pradesh, India.
Ashifha S; Vijayashree J; Vudayana K; Chintada D; P P; G P; Unnikrishnan P
Cureus; 2023 Apr; 15(4):e37596. PubMed ID: 37197134
[TBL] [Abstract][Full Text] [Related]
2. A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India.
Sinha S; Kar C; Das S; Dutta A; De A
Indian J Dermatol; 2024; 69(1):106. PubMed ID: 38572036
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Cutaneous Adverse Drug Reactions (ADR) Reported at an ADR Monitoring Center of a Tertiary Care Teaching Institute in Central India.
Chindhalore CA; Gupta AV; Dakhale GN; Srivastava A
Cureus; 2024 Feb; 16(2):e53706. PubMed ID: 38455795
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of cutaneous adverse drug reactions: a retrospective study of 1883 hospitalized patients from 2007 to 2016 in Shanghai, China.
Yang F; Chen Z; Chen SA; Zhu Q; Wang L; Xiong H; Fu H; Luo X
Eur J Dermatol; 2020 Feb; 30(1):24-31. PubMed ID: 32031529
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
6. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
Turk BG; Gunaydin A; Ertam I; Ozturk G
Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
[TBL] [Abstract][Full Text] [Related]
7. A study of cutaneous adverse drug reactions at a tertiary center in Jammu, India.
Sharma R; Dogra D; Dogra N
Indian Dermatol Online J; 2015; 6(3):168-71. PubMed ID: 26009710
[TBL] [Abstract][Full Text] [Related]
8. Severe cutaneous adverse reactions: A 5-year retrospective study at Hospital Melaka, Malaysia, from December 2014 to February 2020.
Tee CT; Abdullah NH; Kristummoonthy P; Lee CS
Med J Malaysia; 2022 Jul; 77(4):409-414. PubMed ID: 35902928
[TBL] [Abstract][Full Text] [Related]
9. Nevirapine: Most Common Cause of Cutaneous Adverse Drug Reactions in an Outpatient Department of a Tertiary Care Hospital.
Pawar MP; Pore SM; Pradhan SN; Burute SR; Bhoi UY; Ramanand SJ
J Clin Diagn Res; 2015 Nov; 9(11):FC17-20. PubMed ID: 26672558
[TBL] [Abstract][Full Text] [Related]
10. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
Latha S; Choon SE
Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adverse drug eruption: the role of drug patch testing.
Thaiwat S; Rojanapanthu P
Int J Dermatol; 2023 Jan; 62(1):108-114. PubMed ID: 36300773
[TBL] [Abstract][Full Text] [Related]
12. A Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Center in Punjab.
Jha N; Alexander E; Kanish B; Badyal DK
Indian Dermatol Online J; 2018; 9(5):299-303. PubMed ID: 30258795
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
[TBL] [Abstract][Full Text] [Related]
14. A Study of Cutaneous Adverse Drug Reactions and their Association with Autoimmune Diseases at a Tertiary Centre in South-West Rajasthan, India.
Rana S; Gupta K; Agarwal N; Ahamed ANM
Indian J Dermatol; 2021; 66(4):445. PubMed ID: 34759420
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.
Saha A; Das NK; Hazra A; Gharami RC; Chowdhury SN; Datta PK
Indian J Pharmacol; 2012; 44(6):792-7. PubMed ID: 23248414
[TBL] [Abstract][Full Text] [Related]
16. Severe Cutaneous Adverse Drug Reactions at a Tertiary Care Center in Saudi Arabia.
AlJasser MI
Dermatol Res Pract; 2023; 2023():8928198. PubMed ID: 37206671
[TBL] [Abstract][Full Text] [Related]
17. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
Chattopadhyay C; Chakrabarti N
Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous adverse drug reactions among people living with human immunodeficiency virus in a tertiary care hospital in Johor, Malaysia.
Chua KY; Tey KE
Int J STD AIDS; 2022 Aug; 33(9):812-820. PubMed ID: 35775121
[TBL] [Abstract][Full Text] [Related]
19. Drugs and the skin: A concise review of cutaneous adverse drug reactions.
Del Pozzo-MagaƱa BR; Liy-Wong C
Br J Clin Pharmacol; 2022 Aug; ():. PubMed ID: 35974692
[TBL] [Abstract][Full Text] [Related]
20. Trends in culprit drugs and clinical entities in cutaneous adverse drug reactions: a retrospective study.
Wang F; Zhao YK; Li M; Zhu Z; Zhang X
Cutan Ocul Toxicol; 2017 Dec; 36(4):370-376. PubMed ID: 28423957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]